The M184V Substitution in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Delays the Development of Resistance to Amprenavir and Efavirenz in Subtype B and C Clinical Isolates

The M184V substitution in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT), encoding high-level resistance to lamivudine (3TC), results in decreased HIV-1 replicative capacity, diminished RT processivity, and increased RT fidelity in biochemical assays. We assessed the effect o...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Diallo, Karidia, Brenner, Bluma, Oliveira, Maureen, Moisi, Daniela, Detorio, Mervi, Götte, Matthias, Wainberg, Mark A.
Format: Article
Langue:en
Publié: American Society for Microbiology 2003
Sujets:
Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC161854/
https://ncbi.nlm.nih.gov/pubmed/12821504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.7.2376-2379.2003
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC161854/
https://ncbi.nlm.nih.gov/pubmed/12821504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.7.2376-2379.2003

Documents similaires